| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 147.408 | 1.071.586 | 922.637 | 1.306.491 |
| Total Income - EUR | - | - | - | - | - | - | 147.410 | 1.072.129 | 930.160 | 1.387.143 |
| Total Expenses - EUR | - | - | - | - | - | - | 134.740 | 940.265 | 883.238 | 1.278.946 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 12.670 | 131.864 | 46.921 | 108.197 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 11.196 | 122.854 | 39.197 | 92.457 |
| Employees | - | - | - | - | - | - | 2 | 3 | 3 | 5 |
Check the financial reports for the company - Profuraje Bio Impex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 195 | 6.888 | 29.329 | 36.173 |
| Current Assets | - | - | - | - | - | - | 131.283 | 257.231 | 308.109 | 426.567 |
| Inventories | - | - | - | - | - | - | 67.680 | 77.791 | 123.859 | 177.816 |
| Receivables | - | - | - | - | - | - | 19.964 | 89.719 | 84.723 | 139.849 |
| Cash | - | - | - | - | - | - | 43.639 | 89.721 | 99.528 | 108.902 |
| Shareholders Funds | - | - | - | - | - | - | 11.237 | 122.894 | 107.987 | 199.904 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 120.242 | 141.225 | 229.452 | 262.836 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4621 - 4621" | |||||||||
| CAEN Financial Year |
4621
|
|||||||||
Comments - Profuraje Bio Impex S.r.l.